Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elion

Showing results (491-500 of 518) with videos related to

Pageof 52
Sort By:
Journal of the American Society of Nephrology : JASN|March 13, 2015
CC Chemokine Ligand 18 in ANCA-Associated Crescentic GNSilke R Brix, Gesa Stege, Erik Disteldorf, et al.
The Lancet. Infectious Diseases|November 6, 2015
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority studyAnthony Mills, Jose R Arribas, Jaime Andrade-Villanueva, et al.
The Lancet. HIV|May 27, 2017
Safety and tolerability of long-acting cabotegravir injections in HIV-uninfected men (ECLAIR): a multicentre, double-blind, randomised, placebo-controlled, phase 2a trialMartin Markowitz, Ian Frank, Robert M Grant, et al.
Database : the Journal of Biological Databases and Curation|September 4, 2024
Global Globin Network and adopting genomic variant database requirements for thalassemiaHashim Halim-Fikri, Ninie Nadia Zulkipli, Hafiza Alauddin, et al.
JAMA Internal Medicine|November 17, 2015
Preexposure Prophylaxis for HIV Infection Integrated With Municipal- and Community-Based Sexual Health ServicesAlbert Y Liu, Stephanie E Cohen, Eric Vittinghoff, et al.
JAMA|February 24, 2015
Ombitasvir, paritaprevir co-dosed with ritonavir, dasabuvir, and ribavirin for hepatitis C in patients co-infected with HIV-1: a randomized trialMark S Sulkowski, Joseph J Eron, David Wyles, et al.
Blood|September 22, 2017
Degree of anemia, indirect markers of hemolysis, and vascular complications of sickle cell disease in AfricaMarie Dubert, Jacques Elion, Aissata Tolo, et al.
AIDS (London, England)|April 2, 2019
Renal safety of tenofovir alafenamide vs. tenofovir disoproxil fumarate: a pooled analysis of 26 clinical trialsSamir K Gupta, Frank A Post, José R Arribas, et al.
Nature Immunology|October 1, 2025
Spatiotemporal interaction of immune and renal cells controls glomerular crescent formation in autoimmune kidney diseaseZeba Sultana, Robin Khatri, Behnam Yousefi, et al.
Nature Communications|September 19, 2024
Immune profiling-based targeting of pathogenic T cells with ustekinumab in ANCA-associated glomerulonephritisJonas Engesser, Robin Khatri, Darius P Schaub, et al.
Pageof 52

Showing results (491-500 of 518) with videos related to

Sort By:
Pageof 52
Journal of the American Society of Nephrology : JASN|March 13, 2015
CC Chemokine Ligand 18 in ANCA-Associated Crescentic GNSilke R Brix, Gesa Stege, Erik Disteldorf, et al.
The Lancet. Infectious Diseases|November 6, 2015
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority studyAnthony Mills, Jose R Arribas, Jaime Andrade-Villanueva, et al.
The Lancet. HIV|May 27, 2017
Safety and tolerability of long-acting cabotegravir injections in HIV-uninfected men (ECLAIR): a multicentre, double-blind, randomised, placebo-controlled, phase 2a trialMartin Markowitz, Ian Frank, Robert M Grant, et al.
Database : the Journal of Biological Databases and Curation|September 4, 2024
Global Globin Network and adopting genomic variant database requirements for thalassemiaHashim Halim-Fikri, Ninie Nadia Zulkipli, Hafiza Alauddin, et al.
JAMA Internal Medicine|November 17, 2015
Preexposure Prophylaxis for HIV Infection Integrated With Municipal- and Community-Based Sexual Health ServicesAlbert Y Liu, Stephanie E Cohen, Eric Vittinghoff, et al.
JAMA|February 24, 2015
Ombitasvir, paritaprevir co-dosed with ritonavir, dasabuvir, and ribavirin for hepatitis C in patients co-infected with HIV-1: a randomized trialMark S Sulkowski, Joseph J Eron, David Wyles, et al.
Blood|September 22, 2017
Degree of anemia, indirect markers of hemolysis, and vascular complications of sickle cell disease in AfricaMarie Dubert, Jacques Elion, Aissata Tolo, et al.
AIDS (London, England)|April 2, 2019
Renal safety of tenofovir alafenamide vs. tenofovir disoproxil fumarate: a pooled analysis of 26 clinical trialsSamir K Gupta, Frank A Post, José R Arribas, et al.
Nature Immunology|October 1, 2025
Spatiotemporal interaction of immune and renal cells controls glomerular crescent formation in autoimmune kidney diseaseZeba Sultana, Robin Khatri, Behnam Yousefi, et al.
Nature Communications|September 19, 2024
Immune profiling-based targeting of pathogenic T cells with ustekinumab in ANCA-associated glomerulonephritisJonas Engesser, Robin Khatri, Darius P Schaub, et al.
Pageof 52